Neurofibroma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

5 events
Dec 2023Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs

AstraZeneca — NA

TrialACTIVE NOT RECRUITING
Mar 2023Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia

AstraZeneca — NA

TrialACTIVE NOT RECRUITING
Feb 2022Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1

Centre Leon Berard — NA

TrialRECRUITING
Sep 2019MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

SpringWorks Therapeutics, Inc. — PHASE2

TrialACTIVE NOT RECRUITING
Apr 2015Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

National Cancer Institute (NCI) — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Neurofibroma.
Check the disease page for updates →

Clinical Trial Landscape

5 active trials
1Phase 2
1Phase 1
3N/A
5Total recruiting
Search clinical trials for Neurofibroma

Recent News & Research

No recent news articles indexed yet for Neurofibroma.
Search PubMed for Neurofibroma

Browse all Neurofibroma news →

Specialist Network

Top 6 by expertise

View all Neurofibroma specialists →

Quick Actions